Plugging gaps in China’s hepatitis B prevention would be cost effectiveBMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b4420 (Published 28 October 2009) Cite this as: BMJ 2009;339:b4420
- Jane Parry
- 1Hong Kong
A country-wide catch-up hepatitis B vaccination programme in China would save thousands of lives and be cost effective, research from Stanford University has shown (Hepatology 2009 Sep 9, doi:10.1002/hep.23310).
Vaccinating the estimated 150 million children aged 1-19 years who are currently unprotected will cost an estimated $423m (£260m; €281m) but will save the economy $840m, by preventing eight million infections and 65 000 deaths, the researchers found.
Routine free vaccination of babies against the disease began only in 2002, and serological survey data show that 40% of children …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial